Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22COVID-19+infection%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
/vufind/Search/Results?lookfor=%22COVID-19+infection%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
Search /vufind/Search2/Results?lookfor=%22COVID-19+infection%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
PubPharm (126)
1
A phase II study of a candidate COVID-19 vaccine in children (COV006) : A single-blind, randomised, phase II study to determine safety and immunogenicity of the Coronavirus Disease (COVID-19) vaccine ChAdOx1 in UK healthy children and adolescents (aged 6 - 17 years)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Comparing COVID-19 vaccine schedule combinations in adolescents (Com-COV3) : A single-blind, randomised, phase II UK multi-centre study to determine reactogenicity and immunogenicity of heterologous prime/boost COVID-19 vaccine schedules in adolescents
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A phase II study of a candidate COVID-19 vaccine in children (COV006) : A single-blind, randomised, phase II study to determine safety and immunogenicity of the Coronavirus Disease (COVID-19) vaccine ChAdOx1 in UK healthy children and adolescents (aged 6 - 17 years)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Comparing COVID-19 vaccine schedule combinations in adolescents (Com-COV3) : A single-blind, randomised, phase II UK multi-centre study to determine reactogenicity and immunogenicity of heterologous prime/boost COVID-19 vaccine schedules in adolescents
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A randomized, double-blind, placebo-controlled, multicenter study of ensovibep (MP0420) in ambulatory adult patients with symptomatic COVID-19 – The EMPATHY” Trial : A randomized, double-blind, placebo-controlled, multicenter study of ensovibep (MP0420) in ambulatory adult patients with symptomatic COVID-19 – The EMPATHY” Trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A randomized, double-blind, placebo-controlled, multicenter study of ensovibep (MP0420) in ambulatory adult patients with symptomatic COVID-19 – The EMPATHY” Trial : A randomized, double-blind, placebo-controlled, multicenter study of ensovibep (MP0420) in ambulatory adult patients with symptomatic COVID-19 – The EMPATHY” Trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A study of the safety and efficacy of 7 days treatment with BIT225 in patients with COVID-19, compared to placebo, including measurement of antiviral activity, clinical recovery and immune biomarkers. : A Phase 2, Double Blind Placebo-Controlled Study of BIT225, an Orally Administered SARS-CoV-2 Viroporin Inhibitor, to Evaluate Antiviral Activity, Safety, and Immune Biomarkers in Non-Hospitalised Vaccinated and Unvaccinated Adults with COVID-19.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A study of the safety and efficacy of 7 days treatment with BIT225 in patients with COVID-19, compared to placebo, including measurement of antiviral activity, clinical recovery and immune biomarkers. : A Phase 2, Double Blind Placebo-Controlled Study of BIT225, an Orally Administered SARS-CoV-2 Viroporin Inhibitor, to Evaluate Antiviral Activity, Safety, and Immune Biomarkers in Non-Hospitalised Vaccinated and Unvaccinated Adults with COVID-19.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
COVID-19 vaccine boost to enhance immunity (The Booster Study) : COVID-19 vaccine boost to enhance immunity in healthy adults aged 18-65 (The Booster Study)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
COVID-19 vaccine boost to enhance immunity (The Booster Study) : COVID-19 vaccine boost to enhance immunity in healthy adults aged 18-65 (The Booster Study)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 2
Medienart
126
Aufsätze
126
E-Artikel
126
E-Ressourcen
Zeitschriftentitel
112
WHO International Clinical Trials Registry Plat...
14
ClinicalTrials.gov
Thema
126
610
Phase: Phase 2
126
Study Type: Interventional
56
Recruitment Status: Not yet recruiting
46
Recruitment Status: Authorised-recruitment may ...
8
Medical Condition: Infection with SARS-CoV-2 vi...
8
Recruitment Status: Withdrawn
7
COVID-19
6
Medical Condition: Prevention of COVID-19 infec...
6
Medical Condition: Severe COVID-19 Infection Me...
6
Medical Condition: Severe COVID-19 Infection Me...
6
Recruitment Status: Recruiting
5
Laboratory Infection
4
Communicable Diseases
4
Medical Condition: COVID-19 infection MedDRA ve...
3
Infection
3
Infections
3
Medical Condition: COVID-19 Infection
3
Recruitment Status: Completed
3
Recruitment Status: Terminated
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
10
2023
32
2022
47
2021
37
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
124
Englisch
2
Unbestimmt
Haven't found what you're looking for?
Wird geladen...